BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 38812528)

  • 1. Case Report: Holistic dental care for a child with Hunter syndrome: Addressing dental ramifications, overcoming challenges, and enhancing quality of life.
    Saha S; Priya K; Rai K; R M; Shetty K; M Hegde A; Rao K A; Abhijit Tanna D; S M; S S
    F1000Res; 2024; 13():268. PubMed ID: 38812528
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Case report: a rare case of Hunter syndrome (type II mucopolysaccharidosis) in a girl.
    Semyachkina AN; Voskoboeva EY; Zakharova EY; Nikolaeva EA; Kanivets IV; Kolotii AD; Baydakova GV; Kharabadze MN; Kuramagomedova RG; Melnikova NV
    BMC Med Genet; 2019 May; 20(1):66. PubMed ID: 31046699
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Molecular diagnosis of 65 families with mucopolysaccharidosis type II (Hunter syndrome) characterized by 16 novel mutations in the IDS gene: Genetic, pathological, and structural studies on iduronate-2-sulfatase.
    Kosuga M; Mashima R; Hirakiyama A; Fuji N; Kumagai T; Seo JH; Nikaido M; Saito S; Ohno K; Sakuraba H; Okuyama T
    Mol Genet Metab; 2016 Jul; 118(3):190-197. PubMed ID: 27246110
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mucopolysaccharidosis type II with inguinal hernia.
    Rayamajhi A; Pokharel PJ; Chapagain R; Rayamajhi AK
    J Nepal Health Res Counc; 2013 Sep; 11(25):293-5. PubMed ID: 24908534
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Evaluation of Change in Quality of Life, Dental Fear and Dental Anxiety in Young Children Following Full-mouth Dental Rehabilitation under General Anesthesia for Early Childhood Caries.
    Mathew MG; Jeevanandan G; Vishwanathaiah S; Khubrani YM; Depsh MA; Almalki FY
    J Contemp Dent Pract; 2023 Apr; 24(4):250-256. PubMed ID: 37469264
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Hunter syndrome follow-up after 1 year of enzyme-replacement therapy.
    Puiu M; Chirita-Emandi A; Dumitriu S; Arghirescu S
    BMJ Case Rep; 2013 Jan; 2013():. PubMed ID: 23307460
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The mutational spectrum of hunter syndrome reveals correlation between biochemical and clinical profiles in Tunisian patients.
    Chkioua L; Grissa O; Leban N; Gribaa M; Boudabous H; Turkia HB; Ferchichi S; Tebib N; Laradi S
    BMC Med Genet; 2020 May; 21(1):111. PubMed ID: 32448126
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effectiveness of professional oral health care intervention on the oral health of residents with dementia in residential aged care facilities: a systematic review protocol.
    Yi Mohammadi JJ; Franks K; Hines S
    JBI Database System Rev Implement Rep; 2015 Oct; 13(10):110-22. PubMed ID: 26571287
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Home treatment in paediatric patients with Hunter syndrome: the first Italian experience.
    Ceravolo F; Mascaro I; Sestito S; Pascale E; Lauricella A; Dizione E; Concolino D
    Ital J Pediatr; 2013 Sep; 39():53. PubMed ID: 24011228
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Molecular analysis of iduronate -2- sulfatase gene in Tunisian patients with mucopolysaccharidosis type II.
    Chkioua L; Khedhiri S; Ferchichi S; Tcheng R; Chahed H; Froissart R; Vianey-Saban C; Laradi S; Miled A
    Diagn Pathol; 2011 May; 6():42. PubMed ID: 21605424
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Characterization of a HIR-Fab-IDS, Novel Iduronate 2-Sulfatase Fusion Protein for the Treatment of Neuropathic Mucopolysaccharidosis Type II (Hunter Syndrome).
    Gusarova VD; Smolov MA; Lyagoskin IV; Degterev MB; Rechetnik EV; Rodionov AV; Pantyushenko MS; Shukurov RR
    BioDrugs; 2023 May; 37(3):375-395. PubMed ID: 37014547
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mucopolysaccharidosis type II in a female patient with a reciprocal X;9 translocation and skewed X chromosome inactivation.
    Lonardo F; Di Natale P; Lualdi S; Acquaviva F; Cuoco C; Scarano F; Maioli M; Pavone LM; Di Gregorio G; Filocamo M; Scarano G
    Am J Med Genet A; 2014 Oct; 164A(10):2627-32. PubMed ID: 25044788
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A 38.8 kb deletion mutation of the iduronate-2-sulfatase gene in a patient with Hunter syndrome.
    Chou YY; Chao SC; Kuo PL; Lin SJ
    J Formos Med Assoc; 2005 Apr; 104(4):273-5. PubMed ID: 15909065
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prevention of Neurocognitive Deficiency in Mucopolysaccharidosis Type II Mice by Central Nervous System-Directed, AAV9-Mediated Iduronate Sulfatase Gene Transfer.
    Laoharawee K; Podetz-Pedersen KM; Nguyen TT; Evenstar LB; Kitto KF; Nan Z; Fairbanks CA; Low WC; Kozarsky KF; McIvor RS
    Hum Gene Ther; 2017 Aug; 28(8):626-638. PubMed ID: 28478695
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clinical, biochemical and molecular characteristics of Filipino patients with mucopolysaccharidosis type II - Hunter syndrome.
    Chiong MA; Canson DM; Abacan MA; Baluyot MM; Cordero CP; Silao CL
    Orphanet J Rare Dis; 2017 Jan; 12(1):7. PubMed ID: 28077157
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Enzyme replacement therapy in mucopolysaccharidosis type II (Hunter syndrome): a preliminary report.
    Muenzer J; Lamsa JC; Garcia A; Dacosta J; Garcia J; Treco DA
    Acta Paediatr Suppl; 2002; 91(439):98-9. PubMed ID: 12572850
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Multidisciplinary management of Hunter syndrome.
    Muenzer J; Beck M; Eng CM; Escolar ML; Giugliani R; Guffon NH; Harmatz P; Kamin W; Kampmann C; Koseoglu ST; Link B; Martin RA; Molter DW; Muñoz Rojas MV; Ogilvie JW; Parini R; Ramaswami U; Scarpa M; Schwartz IV; Wood RE; Wraith E
    Pediatrics; 2009 Dec; 124(6):e1228-39. PubMed ID: 19901005
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Follow-up of children's oral health-related quality of life after dental general anaesthesia treatment.
    Jankauskiené B; Virtanen JI; Narbutaité J
    Acta Odontol Scand; 2017 May; 75(4):255-261. PubMed ID: 28358287
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Extension of the molecular analysis to the promoter region of the iduronate 2-sulfatase gene reveals genomic alterations in mucopolysaccharidosis type II patients with normal coding sequence.
    Brusius-Facchin AC; Abrahão L; Schwartz IV; Lourenço CM; Santos ES; Zanetti A; Tomanin R; Scarpa M; Giugliani R; Leistner-Segal S
    Gene; 2013 Sep; 526(2):150-4. PubMed ID: 23707223
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Diagnosing Hunter syndrome in pediatric practice: practical considerations and common pitfalls.
    Burton BK; Giugliani R
    Eur J Pediatr; 2012 Apr; 171(4):631-9. PubMed ID: 22383073
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.